Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally.
Repligen stock last closed at $130.00, down 1.59% from the previous day, and has decreased 19.24% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.08 percentage points. Repligen stock is currently +26.26% from its 52-week low of $102.97, and -28.77% from its 52-week high of $182.52.
As of Apr 17, 2025, there are 56.15M shares of RGEN outstanding. The market capitalization of RGEN is $7.30B. In the last 24 hours, 754,658 RGEN shares were traded.
How to Buy Repligen Stock
Not sure how to invest in Repligen stock? Here's how.
Choose where to buy Repligen stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Repligen stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Pick your method of payment and add your info.
Research Repligen stock: The Repligen ticker symbol is RGEN. Is Repligen stock a good investment? Should you buy shares of RGEN? How do RGEN's underlying business fundamentals look? Do top analysts think Repligen is a good buy? Why has RGEN's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if RGEN is a good stock to buy).
Place your RGEN buy order: Decide if you will purchase RGEN shares at the current market price or use a limit order to buy RGEN stock at a given price.
Get the latest scoop on your RGEN position: Create a watchlist to get the latest news on your position in Repligen shares.
Step 1: Choose where to buy Repligen stock
You need a brokerage account in order to access the NASDAQ market and buy RGEN stock.
A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global markets: From Tech to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've picked the best brokerage, you need to fill out some personal details so you are able to invest in RGEN today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Repligen stock
After you have selected the best place to buy Repligen stock, it's important to analyze their stock before you invest, so you actually comprehend the risk and upside.
Repligen Numbers
RGEN Price
$130.00
1w %
12.86%
1y %
-19.24%
5y %
23.09%
P/E
-282.61x
P/B
3.7x
P/S
11.46x
PEG
N/A
Revenue
$634.44M
Earnings
-$25.51M
Fore. Rev. Growth
14.04%
Fore. Earn. Growth
N/A
Market Cap
$7.30B
Next Earnings
Apr 29, 2025
Next Dividend
N/A
RGEN Due Diligence Score
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis.
Last year, RGEN revenue was $634.44M. Over the past 5 year, RGEN's revenue has grown by 18.61% per year. This was faster than the Medical Instruments & Supplies industry average of 8.99%.
No, Repligen doesn't provide an income stream by paying out dividends.
What do other investors have to say about RGEN?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your RGEN buy order
There are two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are mostly the best for newer investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a given dollar amount, place a limit order.
Click the Open Trade button and your broker will place your order.
If you want additional assistance buying stocks on eToro, click the helpful video below:
As of Apr 17, 2025, it costs $130.00 to buy one share of Repligen stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.077 shares of RGEN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.